PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by Xuorescent in situ hybridization

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 2, 2012, Pages 213-220

  Dumont, Sarah N ^a   Lazar, Alexander J ^a   Bridge, Julia A ^b   Benjamin, Robert S ^a   Trent, Jonathan C ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Chromosomal rearrangement; Fluorescent in situ hybridization; PAX FOXO1; Rhabdomyosarcoma; Tissue microarray

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOXO1 PAX3 FUSION GENE; FOXO1 PAX7 FUSION GENE; FUSION GENE; GENE FREQUENCY; GENE LOCUS; GENE PROBE; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE FUSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PAIRED BOX TRANSCRIPTION FACTORS; PAX7 TRANSCRIPTION FACTOR; PROGNOSIS; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84857048155     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1089-7     Document Type: Article

References (28)

1. Asmar L, Gehan EA, Newton WA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, Shimada H, Tsokos M, Harms D et al (1994) Agreement among and within groups of pathologists in the classiWcation of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classiWcations. Cancer 74 (9): 2579-2588 (Pubitemid 24320865)
2. Barr FG, Smith LM, Lynch JC, Strzelecki D, Parham DM, Qualman SJ, Breitfeld PP (2006) Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group. J Mol Diagn 8 (2): 202-208. doi: 10.2353/jmoldx.2006.050124 (Pubitemid 43811243)
3. Bleyer A (2005) The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 35 (5): 182-217. doi: 10.1016/j.cppeds.2005.02.001 (Pubitemid 40521347)
4. Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R (2000) Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and Xuorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosom Cancer 27 (4): 337-344. doi: 10.1002/ (SICI)1098- 2264 (200004)27: 4<337: AID-GCC1>3.0.CO;2-1 (Pubitemid 30127620)
5. Chang B, Pang LJ, Qi Y, Liu CX, Cao Y, Li HA, Hu WH, Jiang JF, Zhang WJ, Li F (2009) PAX-FKHR fusion genes and AChRgamma in Chinese patients with rhabdomyosarcoma: diagnosis using formalin-Wxed archival tissues. Int J Surg Pathol 17 (1): 6-15
6. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13 (3): 610-630
7. Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19 (12): 3091-3102 (Pubitemid 32567502)
8. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to FKHR by the variant t (1;13) (p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54 (11): 2869-2872 (Pubitemid 24187765)
9. Esnaola NF, Rubin BP, Baldini EH, Vasudevan N, Demetri GD, Fletcher CD, Singer S (2001) Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg 234 (2): 215-223 (Pubitemid 32729429)
10. Ferrari A, Dileo P, Casanova M, Bertulli R, Meazza C, Gandola L, Navarria P, Collini P, Gronchi A, Olmi P, Fossati-Bellani F, Casali PG (2003) Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98 (3): 571-580 (Pubitemid 36885998)
11. Hawkins WG, Hoos A, Antonescu CR, Urist MJ, Leung DH, Gold JS, WoodruV JM, Lewis JJ, Brennan MF (2001) Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer 91 (4): 794-803 (Pubitemid 32173305)
12. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56 (2): 106-130
13. Kohashi K, Oda Y, Yamamoto H, Tamiya S, Takahira T, Takahashi Y, Tajiri T, Taguchi T, Suita S, Tsuneyoshi M (2008) Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in diVerential diagnosis of rhabdomyosarcoma subtype. J Cancer Res Clin Oncol 134 (10): 1097-1103. doi: 10.1007/s00432-008-0385-3
14. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Garden AS, Benjamin RS (2002) Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer 95 (2): 377-388. doi: 10.1002/cncr.10669 (Pubitemid 34787604)
15. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, Heyn R, Lawrence W, Newton W, Ortega J et al (1988) The intergroup rhabdomyosarcoma study-I. A Wnal report. Cancer 61 (2): 209-220
16. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J et al (1993) The intergroup rhabdomyosarcoma study-II. Cancer 71 (5): 1904-1922 (Pubitemid 23067412)
17. Miettinen M (1988) Rhabdomyosarcoma in patients older than 40 years of age. Cancer 62 (9): 2060-2065 (Pubitemid 18261838)
18. Morotti RA, Nicol KK, Parham DM, Teot LA, Moore J, Hayes J, Meyer W, Qualman SJ (2006) An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. Am J Surg Pathol 30 (8): 962-968 (Pubitemid 44264944)
19. Parham DM, Ellison DA (2006) Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 130 (10): 1454-1465. doi: 10.1043/1543-2165 (2006)130[1454: RIAACA]2.0.CO;2 (Pubitemid 44520712)
20. Raney RB, Anderson JR, Brown KL, Huh WW, Maurer HM, Meyer WH, Parham DM, Rodeberg DA, Wolden SL, Donaldson SS (2010) Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on intergroup rhabdomyosarcoma study group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology Group. Pediatr Blood Cancer 55 (4): 612-616. doi: 10.1002/pbc.22520
21. Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ, Wharam MD, Wiener ES, Crist WM (2001) The intergroup rhabdomyosarcoma study group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma 5 (1): 9-15.doi: 10.1080/13577140120048890 (Pubitemid 32319864)
22. Rubin BP, Nishijo K, Chen HI, Yi X, Schuetze DP, Pal R, Prajapati SI, Abraham J, Arenkiel BR, Chen QR, Davis S, McCleish AT, Capecchi MR, Michalek JE, Zarzabal LA, Khan J, Yu Z, Parham DM, Barr FG, Meltzer PS, Chen Y, Keller C (2011) Evidence for an unanticipated relationship between undiVerentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 19 (2): 177-191. doi: 10.1016/j.ccr.2010.12.023
23. Scrable H, Witte D, Shimada H, Seemayer T, Sheng WW, Soukup S, Koufos A, Houghton P, Lampkin B, Cavenee W (1989) Molecular diVerential pathology of rhabdomyosarcoma. Genes Chromosom Cancer 1 (1): 23-35
24. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 20 (11): 2672-2679 (Pubitemid 34575640)
25. Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 27 (20): 3391-3397. doi: 10.1200/JCO.2008.19.7483
26. Van Gaal JC, De Bont ES, Kaal SE, Versleijen-Jonkers Y, van der Graaf WT (2011) Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead. Crit Rev Oncol Hematol. doi: 10.1016/j. critrevonc.2011.06.005
27. Williamson D, Missiaglia E, de Reynies A, Pierron G, Thuille B, Palenzuela G, Thway K, Orbach D, Lae M, Freneaux P, Pritchard-Jones K, Oberlin O, Shipley J, Delattre O (2010) Fusion genenegative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 28 (13): 2151-2158
28. Wolden SL, Alektiar KM (2010) Sarcomas across the age spectrum. Semin Radiat Oncol 20 (1): 45-51. doi: 10.1016/j.semradonc.2009.09.003